Regenxbio says Sarepta to pay $39 million to Regenxbio within 10 days of effective date
RGNX•Settlement with Sarepta includes $39 million payment
Sept. 24 (Reuters) - REGENXBIO Inc. RGNX.O:
- REGENXBIO - Sarepta to pay $39 million to Regenxbio within 10 days of effective date - SEC filing
- REGENXBIO - All ongoing patent litigation regarding patents-in-suit to be terminated with prejudice - SEC filing
- REGENXBIO - Agrees not to sue Sarepta or affiliates over existing Elevidys or AAVrh74-based capsids - SEC filing
- REGENXBIO Inc: Co and trustees of University of Pennsylvania entered into settlement agreement with Sarepta Therapeutics Inc
Further company coverage: RGNX.O
